An international investigation reveals that Merck's commercial strategy for its cancer drug Keytruda, which costs over R$20,000 in Brazil, employs complex legal and pricing tactics to control access, thereby making it increasingly inaccessible to many patients worldwide, despite its significant role in treating various cancers and generating billions in revenue. #CancerTreatment #PharmaceuticalIndustry #HealthInequality
www.dw.com
Como um remΓ©dio de ponta contra cΓ’ncer se tornou inacessΓvel
Investigação revela que estratégia comercial da farmacéutica Merck para lucrar e assegurar patente do medicamento oncológico Keytruda vem dificultando o acesso de muitos pacientes ao tratamento.
#MND #HealthInequality #Tofersen
www.yahoo.com
Family walks to Westminster in fight for MND drug
Add Yahoo as a preferred source to see more of our stories on Google.
The family of a 19-year-old with motor neurone disease (MND) are walking from Southampton to Westminster to call for urgent access to a groundbreaking drug.
